Drugs / Recombinant Human Follitropin Alfa
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy4 trials | ||||||
| Phase 3 | NCT04935073 Background | Jun 2021 → Dec 2022 | female infertility | Peking University Third Hospital | Unknown | No outcome recorded |
| Phase 3 | NCT04842825 Comparator | Apr 2021 → Dec 2022 | female infertility | Peking University Third Hospital | Unknown | No outcome recorded |
| Phase 3 | NCT01922193 Comparator | Oct 2013 → Feb 2015 | infertility disorder | Ferring Pharmaceuticals | Completed | No outcome recorded |
| Phase 3 | NCT01923194 Comparator | Oct 2013 → Jul 2015 | anovulation | Ferring Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Recombinant Human Follitropin Alfa | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01922193 ↗ |